Piperidine based MCH antagonists for treatment of obesity and CNS disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 16, 2003
Grant Date -
Oct 23, 2003
app pub date -
Nov 25, 2002
filing date -
Nov 26, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention discloses compounds, which are novel antagonists for melanin-concentrating hormone (MCH), as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such MCH antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully